These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: The effect of amiloride/hydrochlorothiazide combination vs furosemide plus potassium supplementation in the treatment of oedema of cardiac origin.
    Author: Viherkoski M, Huikko M, Varjoranta K.
    Journal: Ann Clin Res; 1981 Feb; 13(1):11-5. PubMed ID: 7018361.
    Abstract:
    In this double-blind multicentre study efficacy and safety of amiloride/hydrochlorothiazide (A/HCTH) combination and furosemide plus potassium supplementation (FUR/P) was compared after four weeks basal period -- FUR/P period. 43 patients entered the double-blind period which lasted for ten weeks. Congestive heart failure was well controlled in both of those treatment groups. There was only one patient (FUR/P-group) whose daily dose had to be increased. According their own evaluation the patients tolerated the A/HCTH combination (48%) better than the FUR/P combination (30%). In the A/HCTH-group one clinically significant case of hypokalaemia was found which caused the therapy to be stopped. In the FUR/P-group two patients discontinued the treatment because of clinical side effects. In the long-term therapy of congestive heart failure hydrochlorothiazide together with potassium-sparing amiloride is a pleasant and effective therapy for patients with normal renal function, but the risk of hypokalaemia must be kept in mind also when using this combination.
    [Abstract] [Full Text] [Related] [New Search]